ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer

DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Meredith Delk as its Executive Vice President and Chief Administrative Officer, effective September 30, 2025.

Meredith Delk brings over 20 years of healthcare leadership experience to InnovAge, and until recently led one of the largest Medicaid PBMs in the country. In this newly created role at InnovAge, Delk will lead InnovAge’s Pharmacy Solutions, Behavioral Health, Home Health, and Therapy service lines as well as serve as Chief External Affairs officer overseeing Government Affairs, Communications, and Marketing.

“Meredith’s deep expertise in both pharmacy and external affairs is a strong fit for InnovAge as we continue to evolve our business to serve more seniors and drive stronger awareness of the PACE model nationally,” said Patrick Blair, CEO. “Meredith brings over two decades of healthcare experience across multiple companies in roles requiring executive operational leadership and execution particularly with government-sponsored programs. Meredith has worked with more than 30 states over the span of her career on significant policy and delivery system transformation changes across multiple Medicaid programs. Her reputation as a thoughtful leader who understands the critical work of delivering results for government partners across the country is well known and we are delighted that she is joining our team.”

Prior to working with InnovAge through her self-founded consulting firm, Delk served as Senior Vice President and General Manager leading the state government solutions division at Prime Therapeutics (previously Magellan Rx) from 2018 to 2024. Prior to that, Meredith led government affairs teams at Magellan Health, Anthem (now Elevance), and Amerigroup Corporation.

Investor Contact
Ryan Kubota
rkubota@innovage.com

Media Contact
Lara Hazenfield
InnovAge Public Relations & Content Creation Manager
lhazenfield@innovage.com

About InnovAge
InnovAge is a market leader in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers and government payors — “win.” As of June 30, 2025, InnovAge served approximately 7,740 participants across 20 centers in six states. https://www.innovage.com/.

This press release was published by a CLEAR® Verified individual.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.